Recurium Equity, Llc Zentalis Pharmaceuticals, Inc. (ZNTL) insider trading activity

ZNTL Quotes by TradingView

Recurium Equity, LLC is > 10% Shareholder of Zentalis Pharmaceuticals, Inc.. Currently has a direct ownership of 14,990 shares of ZNTL, which is worth approximately $52,465. The most recent transaction as insider was on Oct 28, 2020, when has been sold 4,147,940 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15K
0% 3M change
0% 12M change
Total Value Held $52,465

Recurium Equity, LLC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 28 2020
SELL
Other acquisition or disposition
-
4,147,940 Reduced 99.64%
14,990 Common Stock
REL

Recurium Equity, LLC

> 10% Shareholder
San Diego, CA

Track Institutional and Insider Activities on ZNTL

Follow Zentalis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZNTL shares.

Notify only if

Insider Trading

Get notified when an Zentalis Pharmaceuticals, Inc. insider buys or sells ZNTL shares.

Notify only if

News

Receive news related to Zentalis Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ZNTL